Greece will continue using the Covid-19 vaccine developed by AstraZeneca, despite the temporary suspension of such vaccinations decided by other EU countries.
The continued “go ahead” for the AstraZeneca “jab” was decided by members of a national committee of vaccinations, following a spate of reports linking the latter’s vaccine with blood clots.
Although the vaccine-maker and UK regulators presented scientific research pointing to a lack of such a link, some national government nevertheless proceeded with the temporary suspension.
